Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05324579 · ClinicalTrials.gov registry record · NA
Studying the Neuronal Basis of Human Social Cognition
A NA study of Neurosciences, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 2
- Study locations
NCT05324579: Recruiting NA study of Neurosciences, sponsored by Massachusetts General Hospital.
NCT05324579 is a NA study of Neurosciences that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05324579, a NA study of Neurosciences, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 2
- Study locations
Study Summary
This proposal aims to study the role that the dorsal prefrontal cortex plays in human social cognition.
Primary Outcome
Neuronal signals will be recorded during performance of a language-based social task over a 15 minute period. A multinomial logistic regression analyses will be used to evaluate for changes in neuronal activity that are associated with social versus non-social task events. Neuronal activity will be measured as the number of spikes recorded during each event, with each event lasting for approximately one second. Significance threshold will be set to p \< 0.01. The primary outcome measure will be
Conditions Studied
Interventions
- BEHAVIORAL Behavioral testing during neuronal recordings
Study Locations (2)
Massachusetts
- Massachusetts General Hospital - Boston
Rhode Island
- Rhode Island Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-05-20 |
| Est. Completion | 2026-06-01 |
| Phase | NA |
What NCT05324579 shows while recruiting
NCT05324579 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Neurosciences appearing as the primary indexed condition, and to 1 intervention - of which Behavioral testing during neuronal recordings is the first listed.
NCT05324579 reports a single indexed study location in Massachusetts, Rhode Island.
Frequently Asked Questions
What is clinical trial NCT05324579 about?
NCT05324579 is a clinical study titled "Studying the Neuronal Basis of Human Social Cognition". This proposal aims to study the role that the dorsal prefrontal cortex plays in human social cognition.
What is the current status of trial NCT05324579?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2022-05-20. Estimated completion is 2026-06-01.
What conditions does trial NCT05324579 study?
This clinical trial studies the following conditions: Neurosciences.
What interventions are being tested in trial NCT05324579?
The interventions under investigation include: Behavioral testing during neuronal recordings (BEHAVIORAL).
Who is sponsoring clinical trial NCT05324579?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05324579 being conducted?
This trial has 2 study locations across Massachusetts, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neurosciences
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05324579's enrollment target sits among peer trials
20 1769th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI